Assessment of Bone Density of Patients Referred to Arak Densitometry Center from 2016 to 2017: A Cross-Sectional Study

Osteoporosis and subsequent fractures increased mortality and disability. Along with this fact, the demand for diagnostic tests has also increased in recent years, which has created a heavy financial burden on the health system.

The aim of this research was to evaluate the compatibility of the indications of performing the bone density measurement in Arak city with the criteria of the international sociality of clinical densitometry (ISCD).

This cross-sectional study was performed from 2016 to 2017. Patients’ information was extracted from checklists recorded by a bone density measurement expert. Patients who lived in Arak and did not have an underlying condition that reduced the value of the bone mineral densitometry (BMD) test were studied. We collected the information of the patients who had undergone a bone density test at the discretion of their physician.

Here, 816 out of 1,354 bone density tests, requested by non-rheumatologists, were abnormal, and 538 were normal. In the abnormal group, 800 (98%) cases had ISCD indications for BMD application, and only 16 (2%) cases had no indication. However, 636 bone density tests were requested by rheumatologists that 474 were abnormal and 162 were normal, and in the abnormal group, 471 (99.4%) had ISCD indications for BMD, and only 3 (0.6%) cases had no indications.

In many cases, bone mineral density has been requested based on ISCD indications (85.13%), and bone disorders have been well identified (64.83%). The study also demonstrates that BMD requests are common among different specialized groups, and when rheumatologists request a bone density, the test is highly sensitive (99.37%).